William H. Collier
2023
In 2023, William H. Collier earned a total compensation of $3.4M as Former President and Chief Executive Officer at Arbutus Biopharma Corp, a 28% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,897,476 |
|---|---|
| Salary | $637,100 |
| Stock Awards | $627,850 |
| Other | $223,558 |
| Total | $3,385,984 |
Collier received $1.9M in option awards, accounting for 56% of the total pay in 2023.
Collier also received $637.1K in salary, $627.9K in stock awards and $223.6K in other compensation.
Rankings
In 2023, William H. Collier's compensation ranked 245th out of 2,996 executives tracked by ExecPay. In other words, Collier earned more than 91.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 245 out of 2,996 | 92nd |
Division Manufacturing | 131 out of 1,640 | 92nd |
Major group Chemicals And Allied Products | 92 out of 909 | 90th |
Industry group Drugs | 90 out of 872 | 90th |
Industry Pharmaceutical Preparations | 57 out of 630 | 91st |
Source: SEC filing on April 10, 2024.
Collier's colleagues
We found three more compensation records of executives who worked with William H. Collier at Arbutus Biopharma Corp in 2023.
News
Arbutus Biopharma Corp CEO William Collier's 2023 pay jumps 28% to $3.4M
April 10, 2024
Arbutus Biopharma Corp CEO William Collier's 2022 pay slips 18% to $2.6M
April 12, 2023
Arbutus Biopharma Corp CEO William Collier's 2021 pay rises 18% to $3.2M
April 11, 2022
Arbutus Biopharma Corp CEO William Collier's 2020 pay rises 17% to $2.7M
April 8, 2021
Arbutus Biopharma Corp CEO Mark Murray's 2019 pay jumps 50% to $3.8M
April 24, 2020